Pharming Group N.V.

Pharming Group N.V.

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$90,213
$72,447
$106,500
$97,287
Gross Profit
75,668
65,803
85,400
90,216
EBITDA
8,753
1,058
9,406
23,430
EBIT
5,715
-2,058
6,200
20,704
Net Income
1,638
-5,213
5,300
7,548
Net Change In Cash
90,213
72,447
106,500
97,287
Free Cash Flow
-12,765
1,714
10,438
31,956
Cash
158,281
53,104
146,021
112,752
Basic Shares
70,140
70,140
75,766
66,904

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$376,134
$297,200
$245,316
$205,622
Gross Profit
330,634
261,801
220,104
188,060
EBITDA
34,782
16,315
9,877
33,533
EBIT
23,566
245
-6,048
20,345
Net Income
2,851
-11,841
-10,548
13,674
Net Change In Cash
376,134
297,200
245,316
205,622
Free Cash Flow
53,953
-2,591
-18,766
20,481
Cash
146,021
56,893
61,741
207,342
Basic Shares
71,317
68,918
65,702
84,284

Earnings Calls

QuarterEPS
2026-06-30
$0.02
2026-03-31
-$0.07
2025-12-31
$0.07
2025-09-30
$0.01